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Abstract: For many years, acetylcholine has been known to contribute to the 
control of breathing and sleep. To probe further the contributions of 
cholinergic rostral pontine systems in control of breathing, we designed this 
study to test the hypothesis that microdialysis (MD) of the muscarinic 
receptor antagonist atropine into the pontine respiratory group (PRG) would 
decrease breathing more in animals while awake than while in NREM sleep. In 
16 goats, cannulas were bilaterally implanted into rostral pontine tegmental 
nuclei (n = 3), the lateral (n = 3) or medial (n = 4) parabrachial nuclei, or the 
Kölliker-Fuse nucleus (KFN; n = 6). After >2 wk of recovery from surgery, the 
goats were studied during a 45-min period of MD with mock cerebrospinal 
fluid (mCSF), followed by at least 30 min of recovery and a second 45-min 
period of MD with atropine. Unilateral and bilateral MD studies were 
completed during the day and at night. MD of atropine into the KFN at night 
decreased pulmonary ventilation and breathing frequency and increased 
inspiratory and expiratory time by 12–14% during both wakefulness and 
NREM sleep. However, during daytime studies, MD of atropine into the KFN 
had no effect on these variables. Unilateral and bilateral nighttime MD of 
atropine into the KFN increased levels of NREM sleep by 63 and 365%, 
respectively. MD during the day or at night into the other three pontine sites 
had minimal effects on any variable studied. Finally, compared with MD of 
mCSF, bilateral MD of atropine decreased levels of acetylcholine and choline 
in the effluent dialysis fluid. Our data support the concept that the KFN is a 
significant contributor to cholinergically modulated control of breathing and 
sleep. 
Keywords: non-rapid eye movement sleep, pons 
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For many years, acetylcholine (ACh) has been known to play a 
role in the control of breathing14 and sleep.3 In the medial pontine 
reticular formation (mPRF), endogenous ACh release causes state-
dependent changes in respiratory control2 and can stimulate rapid eye 
movement (REM) sleep.22 Microadministration of the cholinergic 
agonists carbachol (mixed cholinergic agonist), bethanechol 
(muscarinic agonist), and neostigmine (acetylcholine esterase 
inhibitor) into the mPRF are all known to generate this effect,1,2,18,22,27 
whereas the muscarinic antagonist atropine can block this effect.1 
Indeed, mPRF cholinoceptive mechanisms can cause state-dependent 
changes in the firing rates of respiratory neurons in the parabrachial 
nuclei.16 These studies provide evidence of anatomic connectivity from 
the mPRF to the pontine respiratory group (PRG). Evidence of 
projections in the reverse direction, from the PRG to the mPRF, is 
provided by microinjection of fluorescent dyes into the PRG, resulting 
in ipsi- and contralateral positive regions in the mPRF as well as in the 
dorsal respiratory group and ventral respiratory group in the 
medulla.20 However, studies of the connectivity between brain stem 
respiratory neurons performed using chronically implanted arrays of 
microelectrodes emphasized “a sparse distribution of functional 
connections,” which suggests that interactions between brain stem 
neurons include less direct pathways.29,32 
Through interactions between brain stem respiratory neurons, 
PRG neurons contribute not only to respiratory phase switching7,10,11,36 
but also to multiple aspects of ventilatory control, including a 
postulated critical role in dampening respiratory instabilities during 
sleep.7,14,16,20,24 Many of the concepts regarding the role of cholinergic 
modulation of breathing during sleep are based on studies during REM 
sleep induced by cholinergic mimetics. These studies have led to the 
hypothesis that “central cholinergic neurotransmission in reticular 
regions known to generate REM sleep can contribute to state-
dependent respiratory depression”.22 However, there have been 
relatively few studies on the contribution of cholinergic modulation to 
the changes in breathing and respiratory muscle activity between 
wakefulness and NREM sleep. Accordingly, the primary aim of the 
present study was to determine the effects on breathing and 
respiratory muscle activity during wakefulness and spontaneous NREM 
sleep of reverse microdialysis (MD) of atropine into PRG subnuclei. 
PRG neuronal activity is lower during NREM sleep than during 
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wakefulness,16,30,33 and since this change could be due to reduced 
mPRF cholinergic modulation during NREM sleep, we reasoned that 
muscarinic receptor activity in the PRG would be greater during 
wakefulness than during NREM sleep. The major effect of ACh receptor 
activation is excitation of respiratory neurons;5,6,34 thus the 
administration of the ACh antagonist atropine should decrease 
excitation more during wakefulness than during NREM sleep. 
Accordingly, we hypothesized that MD of atropine into the PRG would 
depress breathing more during wakefulness than during NREM sleep. 
Methods 
For our studies, we used adult goats because their large size 
permitted chronic implantation of stainless steel cannulas into the 
brain stem, enabling MD of target sites. Furthermore, the status of 
ventilatory parameters in goats has been well documented in our 
laboratory from previous studies in the medulla and cerebellum. 
Physiological data were acquired from 16 female adult goats weighing 
46.4 ± 1.9 kg. Six additional goats were used for histological purposes 
only (44.1 ± 2.9 kg). Goats were housed and studied in an 
environmental chamber with a fixed ambient temperature and 
photoperiod. All goats were allowed free access to hay and water, 
except during periods of study, for which they were trained to stand 
comfortably in a stanchion. All aspects of the study were reviewed and 
approved by the Medical College of Wisconsin Animal Care Committee 
before the studies were initiated. 
Surgical procedures.  
Animals were anesthetized with a mixture of ketamine and 
xylazine (15 and 1.25 mg/kg, respectively), intubated, and 
mechanically ventilated with 2.5% isoflurane in 100% oxygen. All 
surgeries were performed under sterile conditions. A preparatory 
surgery was first performed in which a 5-cm segment of each carotid 
artery was isolated from the vagus and elevated subcutaneously to 
facilitate future placement of chronic catheters for sampling and 
monitoring. Bipolar electromyographic (EMG) electrodes were 
implanted into the genioglossus, thyroid arytenoid, posterior 
cricoarytenoid, and thyropharyngeus muscles through an anterior 
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midline incision in the neck and were exteriorized through the skin. 
EMG electrodes were also implanted in duplicate into both the 
diaphragm and abdominal muscles. These EMG electrodes allowed 
recording of upper airway and pump muscles activities for assessment 
of respiratory rhythm and pattern as well as for detection of swallows. 
For monitoring and scoring of sleep state, electroencephalographic 
(EEG) and electrooculographic (EOG) electrodes were implanted in the 
midline cranium and superior orbital ridge, respectively. Ceftiofur 
sodium (Naxcel; 4 mg/kg im) was administered once daily (QD) for 1 
wk postoperatively to minimize infection. Buprenorphine hydrochloride 
(Buprenex; 0.005 mg/kg im) was administered twice daily (BID) for 2 
days to mitigate pain. 
After ≥3 wk, a second surgery was performed to chronically 
implant stainless steel unilateral or bilateral cannulas (70-mm length, 
1.27-mm outer diameter, 0.84-mm inner diameter) into multiple sites 
within the rostral pons. On full recovery, the cannulas were used for 
focal microadministration of atropine to target brain areas. An occipital 
craniotomy was created through a posterior midline incision, and the 
dura mater was excised to expose the posterior cerebellum and 
medulla for visualization of obex. To standardize stereotaxic 
coordinates, the orientation of the dorsal medullary surface, obex, and 
midline were used to determine the dorsoventral, rostrocaudal, and 
mediolateral planes, respectively. In our first few animals, cannulas 
were implanted perpendicular to the brain stem, rostral to the 
transverse sinuses, lateral to the superior sagittal sinus, and through 
the rostral cerebellum. The tip of the cannula in these animals was 
rostral to the PRG in pontine tegmental nuclei, but these animals were 
useful in providing anatomical controls to our PRG-implanted animals. 
To target the PRG in general and to target specific subnuclei within the 
PRG, an “angled” approach was adopted. Cannulas were inserted 
caudal to the confluences of sinuses, through the midcerebellum, at 
angles of 10.5–24° from normal (relative to the dorsal medullary 
surface), depending on the desired rostrocaudal coordinates. Given the 
subnucleus of choice, cannula implantation coordinates were adjusted 
within a range of coordinates: 0–2 mm ventral, 4–5 mm lateral, and 
20–24 mm rostral to respective reference points. Using different 
coordinates in this way, we implanted cannulas at different sites within 
the PRG in 13 individual animals. After placement, cannulas were 
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anchored to the surrounding bone using screws and dental acrylic, and 
a stainless steel stylet was inserted to maintain patency. 
Experienced laboratory personnel continuously monitored the 
goats (for at least 24 h) after brain surgery until stable conditions 
were achieved. Buprenorphine was administered for pain as previously 
explained. Chloroamphenicol (20 mg/kg iv) was administered three 
times daily (TID) for 3 days to minimize infection, as was 
dexamethasone (0.4 mg/kg decreasing to 0.05 mg/kg iv, TID) for 7 
days to minimize swelling. Thereafter, until death, centiofur sodium 
and gentamycin (Gentamax 100; 6 mg/kg im, QD) were administered. 
Physiological measurements.  
Studies commenced ≥2 wk after the brain surgery. For all 
studies, a custom-fitted mask was secured to the goat's muzzle, with a 
two-way breathing valve attached to the mask. A pneumotach was 
attached in series with the inspiratory side to measure flow via a 
Windaq computer data acquisition system. A spirometer was 
connected to the expiratory side, allowing determination of expired 
volume and concentrations of CO2 and O2 to calculate metabolic rate. A 
chronically placed catheter in the elevated carotid artery was used to 
continuously record arterial blood pressure and heart rate and for 
collection of blood samples to obtain arterial pH (pHa), Pco2 (PaCO2), 
and Po2 values (PaO2). Body temperature was measured rectally at 
regular intervals. 
In vivo microdialysis.  
The MD probes (CMA Microdialysis, Solna, Sweden) were 72 mm 
(70-mm shaft and 2-mm membrane) in total length and were inserted 
through the stainless steel cannula such that only the membrane (0.5-
mm diameter, 20-kDa molecular mass cutoff) penetrated the brain 
tissue. The probes were secured in place before the study began and 
remained there for the duration of the protocol. The dialysate was 
mock cerebrospinal fluid (mCSF: 124 mM NaCl, 2.0 mM KCl, 2.0 mM 
MgCl2, 1.3 mM K2PO4, 2.0 mM CaCl2, 11 mM glucose, and 26 mM 
NaHCO3 in sterile distilled H2O) with or without atropine. In a 
tonometer, this solution was heated to 39°C and equilibrated with a 
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physiological gas mixture (6.4% CO2-21% O2-balance N2). MD probes 
were double-barreled, allowing delivery and, in a subset, collection of 
the dialysate. Affluent dialysate was delivered (50 μl/min) using a 
syringe pump, and in a subset, effluent dialysate was collected in 
modified Eppendorf tubes for subsequent content analysis using liquid 
chromatography-electrochemistry (LC-EC). The syringes containing 
mCSF or atropine were connected to the MD probes by 150 cm of 
polypropylene microtubing, allowing isolation of the animal away from 
the syringe pump and associated activities. 
The study protocol consisted of a 30-min control period followed 
by a 45-min period of MD (50 μl/min) with mCSF, a 30-min recovery 
period, a second 45-min period of MD with atropine (50 mM in mCSF), 
and, finally, another 30 min of recovery. The atropine concentration, 
flow rate, and dialysis period of 45 min were chosen because in in vitro 
studies, these parameters were sufficient for delivery of atropine 
across the membrane of the probe (Table 1). The duration of the 
recovery period was chosen because in initial studies, any effects of 
MD had usually been alleviated by 30 min after MD was terminated. 
Thus total study duration was ≥3 h. Of note, the first 7–8 min of the 
second period of MD with atropine actually included delivery of the 
mCSF, which remained in the polypropylene microtubing from the first 
MD period. Thus any effects observed within the first 7–8 min of the 
second MD period could not be due to atropine. Arterial blood was 
sampled over the last 5 min of control, MD, and recovery periods and 
analyzed for PaO2 (Torr), PaCO2 (Torr), and pHa (pH units) (model 248; 
Bayer Diagnostics). 
Table 1. Differences in ACh and choline concentrations in response to 
microdialysis of mCSF and atropine in KFN, MPBN, and LPBN 
 Difference in Concentration, μM/ml 
 
 ACh 
 
Choline 
 
 Unilateral Bilateral Unilateral Bilateral 
Mean ± SE 0.18 ± 0.17 −0.63 ± 0.20 0.01 ± 0.11 −0.43 ± 0.19 
t-test P value 0.929 0.027 0.936 0.053 
KFN −0.12 −1.3 −0.28 −0.04 
 −0.25 −0.53 −0.16 −0.09 
 +0.37 −0.08 −0.28 +0.12 
 −0.15 +0.05 +0.81 −0.06 
 −1.41  +0.01  
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 Difference in Concentration, μM/ml 
 
 ACh 
 
Choline 
 
 Unilateral Bilateral Unilateral Bilateral 
   −0.09  
   −0.05  
   0  
   −0.19  
   −0.17  
   −0.73  
MPBN −0.21 −1.22 −0.11 −1.18 
 +0.11 −0.1 −0.06 −0.31 
 +0.04 −2.26 −0.47 −0.17 
 −0.03 −0.25 −0.27 −0.04 
 −0.35  −0.31 −2.24 
   0.00 −0.06 
   0.00  
   −0.62  
LPBN +1.14 −0.01 +1.36 −0.04 
 +1.07 −0.59 +1.35 −1.09 
 +0.02 −0.62 +0.01 −0.44 
Compared with bilateral microdialysis (MD) of mock cerebral spinal fluid (mCSF), 
bilateral MD of atropine significantly (P < 0.05) decreased the concentrations of both 
ACh and choline in the effluent dialysis fluid. Unilateral MD of atropine did not 
significantly (P > 0.05) affect ACh or choline concentration in the effluent dialysis fluid. 
Each value (mean ± SE) is the difference in concentration of ACh or choline between 
MD of mCSF and atropine. Data were obtained during MD into the Kölliker-Fuse 
nucleus (KFN) and the lateral (LPBN) and medial parabrachial nuclei (MPBN). Values in 
bold type were obtained from studies at night, and the remainder were obtained from 
studies during the day. We were unable to obtain separate values at night for awake 
and non-rapid eye movement (NREM) sleep states. 
MD studies were conducted on six separate days, three during 
the day (9:00 AM to noon) and three during the night (10:00 PM to 
1:00 AM). The studies at night directly tested the hypothesis regarding 
a state-dependent role of pontine cholinergic modulation of breathing. 
The studies during the day provide information on whether pontine 
cholinergic modulation is a determinant of breathing while goats are 
awake during the day and to explore possible circadian influences on 
the cholinergic system. Studies were never completed on consecutive 
days, and studies were separated by at least 36 h. The six MD studies 
consisted of four unilateral studies (left and right cannulas during the 
day and night) and two bilateral studies (bilateral cannulas during the 
day and night). The sequence of the four unilateral studies was 
randomly determined, as was the sequence of the two bilateral 
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studies. Because we were unsure whether there would be a carryover 
effect of atropine or an effect of inserting the dialysis probe, the 
unilateral studies were always completed before the bilateral studies; 
thus, at each unilateral site, the data obtained were not complicated 
by previous dialysis. For daytime studies, animals were loosely tied in 
a stanchion so that they could not assume sternal recumbency, which 
is the preferred sleep posture for goats. For studies conducted at 
night, goats were not allowed to assume sternal recumbency between 
4:00 PM and 10:00 PM in an effort to consolidate sleep. However, 
goats were still permitted free access to food and water during this 
time. At 10:00 PM, when the nighttime study commenced, ties were 
removed so that the goat could assume sternal recumbency within the 
stanchion. All connections to the animal were adjusted to 
accommodate this increased range of motion. 
In vitro microdialysis.  
To confirm delivery of atropine across the MD probe membrane, 
an Eppendorf tube (reservoir) was filled with either 0.6 or 1.5 μl of 
mCSF. A stainless steel cannula was passed through a hole bored in 
the reservoir cap. A MD probe was inserted through the cannula into 
the reservoir, and all connections were sealed with silicon gel. Atropine 
(50 mM) in mCSF was dialyzed for 45 min. Subsequently, the reservoir 
atropine concentration was determined using liquid chromatography-
mass spectrometry (LC-MS). 
Data and statistical analyses.  
Pulmonary ventilation (V ̇i; l/min), breathing frequency (f; 
breaths/min), tidal volume (Vt; l/min), expiratory (Te; s) and 
inspiratory times (Ti, s), respiratory muscle activity (mV), and, in 
addition for night studies, EEG and EOG activities were analyzed on a 
breath-by-breath basis. First, the blood pressure and airflow signals 
were calibrated against known values, whereas EMG signals were 
zeroed at the baseline. The calibrated signals were rectified and time 
averaged. During the experimental control periods, these rectified and 
time-averaged signals were used to recalibrate the EMG signals with 
the assignment of arbitrary peak (1) and baseline values (0). These 
recalibrated EMG signals were again rectified and time averaged. This 
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recalibration and further processing of the EMG signals was necessary 
because of the absence of known values and provided a measure of 
relative magnitude within studies. Finally, the signals were converted 
to a .txt file and input into a custom-designed program that output all 
parameters on a breath-by-breath basis. 
The EEG and EOG activities were used to visually distinguish 
between states of consciousness. Wakefulness was characterized by a 
high-frequency, low-voltage EEG, with variable EOG activity. Non-rapid 
eye movement (NREM) sleep was characterized by a low-frequency 
(<2 Hz), high-voltage (2–3 times greater than that found in 
wakefulness) EEG, with absent EOG activity. REM sleep was 
characterized by a high-frequency, low-voltage EEG, similar to 
wakefulness but concurrent with frequent and distinct bursting activity 
(>30 μV) in the EOG. For night studies, each breath was categorized 
as awake, NREM sleep, or REM sleep. The breaths were then further 
categorized as “quiet,” regular breaths or those that were 
“irregular/disrupted,” characterized by any respiratory muscle activity 
that was inappropriate, including swallowing, coughing, mastication, 
and eructation, as well as any abnormal patterns that could not be 
identified as a specific behavior. The rationale for this second 
categorization was as stated by Bolser et al.:8 “the presence of 
elements that are normally silent in close proximity to spontaneously 
active respiratory neurons raises the possibility that some 
interventions that are intended to study the neurogenesis of breathing 
might instead be influencing components of the holarchical system 
that are only conditionally active;” thus it was essential to make a 
delineation between the two types of breaths (nondisrupted vs. 
disrupted). The data reported are for periods of nondisrupted 
breathing. 
Breath-by-breath values were averaged into 15-min bins and 
expressed in either their raw form or as a percentage of the bins in the 
control period. The 15-min bin values for the two unilateral studies on 
each goat were averaged, and statistical analyses of the unilateral 
data were performed using the averaged values. One-way analysis of 
variance (ANOVA) was used on all ventilatory variables for control 
periods to determine whether there were chronic changes as a result 
of cannula implantation and/or the series of MD studies. Tukey's post 
hoc test was used to identify specific changes. To test whether the 
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measured variables (expressed as a percentage of control) changed 
over the 180 min of the MD protocol and whether there were 
differences between goats with different sites of cannula implantation, 
a two-way ANOVA (time and site as factors) was used. If the ANOVA 
was significant, then Tukey's post hoc analysis was used to determine 
which values during dialysis and recovery differed from the control 
period. This analysis was completed for MD studies while goats were 
awake during the day and also for MD studies at night during the 
awake and NREM sleep states. These analyses were performed for 
both the unilateral and bilateral data. 
The breath-to-breath coefficient of variation (CV) (SD/mean × 
100) was also calculated for each 15-min bin for all ventilatory 
variables, and ANOVA and Tukey's test were used to establish 
statistical significance. For night studies, respective states are reported 
as a percentage of the total time per 15-min bin, and ANOVA and 
Tukey's test were used to determine whether the percentage of time in 
NREM sleep changed over the 180 min and whether there were 
differences between the groups. There was insufficient data during 
REM sleep for statistical analysis. The number of apneas (apnea Te ≥ 
2.5 × average Te) and augmented breaths (augmented breath Vt ≥ 
2.5 × average Vt) were tabulated for each 15-min bin. Apneas 
following augmented breaths were not included in the apnea analyses. 
ANOVA and Tukey's test were used to determine whether the number 
of apneas and augmented breaths changed over the 180-min protocol 
and whether there were group differences. To test whether levels of 
ACh and choline were significantly (P < 0.05) different between mCSF 
and atropine MD, a paired t-test was performed on effluent dialysate 
LC-EC raw values. 
Histological analyses.  
After completion of this experimental protocol, in all but one 
goat, we injected ibotenic acid (IA) into the PRG to determine the 
ventilatory effects of neurotoxic lesions (data not reported). One week 
after the last IA injection, the goats were euthanized (Beuthansia; 
intravenously), and the brain was perfused with physiological buffer 
solution (PBS) and fixed with 4% paraformaldehyde (PFA) in PBS. The 
brain stem was excised and placed in 4% PFA in PBS for 24 h and then 
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in 20 and 30% sucrose solutions, sequentially. The brain stem was 
frozen and serially sectioned (25 μm) from obex to the superior 
colliculi in a transverse (n = 21) or sagittal (n = 1) plane, and the 
sections were adhered to gelatin-chrome-alum-coated slides. Sections 
were acquired such that every fourth section was contained within a 
respective “series.” Thus there were four series in total; within a 
series, each section was 100 μm from the next section in sequence, 
allowing for high-resolution neuronal and anatomical profiling. One 
series was stained for Nissl substance to profile the total number of 
neurons. A second series was stained for muscarinic type-2 (M2) 
immunoreactivity by complexing anti-M2 receptor primary antibody 
(Millipore; 1:200 dilution) with biotinylated anti-mouse secondary 
antibody (Vector; 1:100 dilution). After the antibody-antigen complex 
was incubated, it was localized by avidin (Vector ABC Elite) and 
developed with diaminobenzene. The three PRG nuclei heavily stain for 
the M2 receptor in contrast to an absence of staining in the superior 
cerebellar peduncle; thus this series was used to identify the area of 
the lateral (LPBN) and medial parabrachial nuclei (MPBN) and KFN. 
The third and fourth sections in each series were used for purposes 
unrelated to this report. 
Since the 2 mm of the MD probe membrane were inserted 2 mm 
beyond the tip of the cannula, the major effect of MD would be on 
neurons 2 mm distal to the tract created by the cannula. Thus the 
goats were grouped according to identification of the distal end of the 
cannula tract visualized on the Nissl- and M2-stained sections. 
Accordingly, there were three, four, six, and three goats in the LPBN, 
MPBN, KFN, and rostral pontine tegmental nuclei (RPTN) groups, 
respectively. 
The Nissl- and M2-stained sections in the control goats were 
used to establish the morphology of the LPBN, MPBN, and KFN. The 
nuclei were identified as described above, and then the Nissl-stained 
sections were used to manually count the total number of neurons and 
determine the area of each subnucleus (Metamorph software and 
standardized procedures). 
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Results 
Histology and cannula placement.  
Figure 1, A and B, shows Nissl-stained sagittal and transverse 
sections as well as sections immunostained for the M2 receptor. The 
extensive M2 staining is consistent with a potential role of cholinergic 
modulation in the role of the rostral pons in the control of breathing.25 
As shown by these sections and the schematic in Fig. 1B, the LPBN 
and MPBN flank the superior cerebellar peduncle (SCP), and the KFN 
extends ventral and lateral to the LPBN and MPBN. As shown in Fig. 2, 
A and B, in goats, the morphology of the LPBN and MPBN is quite 
different from that of the KFN. The KFN is quite confined, spanning 
only 2–3 mm rostrocaudally, whereas the LPBN and MPBN are more 
widespread, spanning a rostrocaudal distance of 6–8 mm, and are thus 
larger areas and include more neurons than the KFN (Fig. 2B). 
Accordingly, we presume that MD of atropine in the KFN likely 
attenuated muscarinic activity of a larger percentage of total KFN 
neurons than when atropine was MD in the LPBN and MPBN. 
 
Fig. 1. Histochemical and immunohistochemical staining for Nissl substance and 
muscarinic type-2 (M2) receptors provides anatomic characterization of the pontine 
respiratory group in goats. A: sagittal sections (from a control goat) 4.9 mm lateral to 
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the midline show the location in the rostral, dorsal pons of the lateral (LPBN) and 
medial parabrachial nuclei (MPBN) and the Kölliker-Fuse nucleus (KFN) relative to the 
cerebellar peduncle (SCP). B: transverse Nissl- and M2-stained sections from another 
control goat and a schematic to further illustrate the location of the LPBN, MPBN, and 
KFN. The superior and inferior colliculus (IC), trigeminal motor nucleus,5 basal pons 
(BP), facial nucleus,7 and nucleus ambiguus (NA) are labeled for reference. D, dorsal; 
V, ventral; R, rostral; C, caudal; M, medial; L, lateral. 
 
 
Fig. 2. In the rostrocaudal direction of control goats, there are changes in the 
anatomy of the LPBN, MPBN, and KFN. A: immunohistochemically stained 
hemisections for the M2 receptors of a control goat and a schematic illustrating the 
location of the LPBN, MPBN, and KFN at 7 different rostrocaudal distances from the 
peak (pKFN) number of neurons in the KFN. B: plots of the number of neurons in the 
LPBN, MPBN, and KFN of control goats at different rostrocaudal distances relative to 
the pKFN. Among the 3 subnuclei, note the differences in number of neurons 
rostrocaudally. Filled symbols indicate unilateral neuron counts from individual goats; 
open symbols indicate the mean of all control goats. 
Verification of MD efficacy.  
In vitro dialysis confirmed that atropine moved across the probe 
membrane. The concentration of atropine in the mCSF within the 
reservoir was 76 and 97 μM for reservoir volumes of 1,500 and 600 μl, 
respectively. 
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We did not measure atropine in PRG tissue during in vivo MD, 
but indirect evidence of a significant movement of atropine into the 
tissue was provided by the finding that bilateral MD of atropine 
decreased ACh and choline levels in the MD effluent fluid. Limited data 
were obtained for each PRG site, but in three of four KFN sites, four of 
four MPBN sites, and three of three LPBN sites, there was less ACh in 
the effluent sample after MD of atropine than after MD of mCSF (Table 
1). The same consistent decrease was found in effluent choline 
concentration. Pooling the data yielded a mean difference for ACh of 
−0.63 ± 0.2 μM/ml (P < 0.027) and for choline of −0.043 ± 0.19 
μM/ml (P < 0.053). During unilateral MD, there was no significant 
difference in either ACh or choline concentration between mCSF and 
atropine MD (Table 1). 
Breathing.  
V ̇i was significantly (P < 0.05) reduced 2 wk after implantation 
of the cannulas compared with preimplantation studies (Table 2). 
These decreases were due primarily to a reduction in Vt (Table 2) and 
were secondary to a reduction in metabolic rate (data not shown). 
Breathing frequency and arterial blood gases were not altered by 
implanting the cannulas (Table 2). There were no significant (P < 
0.05) changes in any ventilatory variable between the control periods 
before the MD studies were initiated and a control period after the final 
MD study; thus there was no apparent chronic effect of atropine MD on 
eupneic breathing. 
Table 2. Effects of cannula placement on physiological parameters 
 V̇i, l/min f, breaths/min Vt, l/breath PaCO2, Torr PaO2, Torr 
RPTN 
    Preimplant 7.60 ± 0.98 20.68 ± 2.83 0.40 ± 0.02 39.1 ± 1.0 97 ± 5 
    Postimplant 6.47 ± 0.67* 19.46 ± 2.06 0.38 ± 0.03* 39.8 ± 1.6 91 ± 6 
    Post-Atr MD 6.48 ± 0.23* 21.34 ± 1.98 0.36 ± 0.02* 40.1 ± 1.7 97 ± 5 
LPBN 
    Preimplant 8.59 ± 1.25 16.56 ± 0.60 0.53 ± 0.07 39.6 ± 0.4 104 ± 11 
    Postimplant 6.76 ± 1.18* 19.77 ± 1.60 0.38 ± 0.07* 40.3 ± 1.5 92 ± 11 
    Post-Atr MD 6.67 ± 0.30* 17.85 ± 1.72 0.42 ± 0.04* 41.3 ± 0.7 97 ± 3 
MPBN 
    Preimplant 6.27 ± 0.43 16.47 ± 0.90 0.40 ± 0.04 41.6 ± 0.7 101 ± 4 
    Postimplant 6.39 ± 0.60 18.63 ± 1.46 0.35 ± 0.02* 43.1 ± 1.8 92 ± 6 
    Post-Atr MD 6.31 ± 0.58 19.11 ± 0.98 0.34 ± 0.02* 43.8 ± 1.8 102 ± 6 
KFN 
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 V̇i, l/min f, breaths/min Vt, l/breath PaCO2, Torr PaO2, Torr 
    Preimplant 7.79 ± 0.78 17.84 ± 1.16 0.46 ± 0.04 41.2 ± 0.7 97 ± 4 
    Postimplant 6.77 ± 0.30* 17.93 ± 1.06 0.40 ± 0.02* 39.7 ± 0.4 92 ± 2 
    Post-Atr MD 6.85 ± 0.36* 16.16 ± 1.23 0.47 ± 0.04 39.9 ± 0.6 101 ± 3 
After implantation of the cannula, pulmonary ventilation (V̇i) was significantly reduced 
from preimplantation studies, and these effects were generally due to a reduction in 
tidal volume (Vt).  
*P < 0.05, significant differences from preimplantation studies. Breathing frequency (f) 
and arterial blood gases (PaCO2, PaO2) were not significantly (P > 0.05) changed by 
implantation of the cannula. 
As shown in Fig. 3 for four different individual goats, during MD 
into three of the four rostral pontine sites, V ̇i was stable throughout 
the 3 h of the daytime and nighttime studies. Indeed, neither 
unilateral nor bilateral MD of either mCSF or atropine during daytime 
studies significantly (P < 0.05) affected V ̇i, f, Ti, or Vi regardless of 
cannula site (Fig. 4). However, in goats with unilateral daytime MD of 
atropine into the LPBN, Te was increased (P < 0.05) by 19% during 
the recovery period (Fig. 3). 
 
Fig. 3. Pulmonary ventilation (V̇i) of 4 different goats during microdialysis (MD) of 
mock cerebrospinal fluid (mCSF) or atropine in studies during the day in the awake 
state and in studies at night during the awake and NREM sleep states. The MD was in 
either the rostral pontine tegmental nucleus (RPTN) or in the LPBN, MPBN, or KFN. 
Note the relatively stable V̇i throughout the protocol for all goats except that for the 
nighttime studies in the KFN goat, V̇i decreased during atropine MD in both the awake 
and NREM sleep states. Shaded boxes indicate periods of MD with either mCSF or 
atropine. 
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Fig. 4. Neither unilateral nor bilateral MD of either mCSF or atropine during daytime 
studies had any significant effect on ventilatory parameters, with the exception of an 
increase in expiratory time (Te) following unilateral MD of atropine into the LPBN (n = 
3). Data were obtained during MD in the RPTN (n = 3), MPBN (n = 4), or KFN (n = 6). 
f, Breathing frequency; Ti, inspiratory time. Shaded boxes indicate periods of MD with 
either mCSF or atropine. *P < 0.05, significant differences from control. 
As also shown in Fig. 3, the exception to the stable V ̇i during the 
MD studies was during MD of atropine into the KFN at night, when V ̇i 
decreased during both the awake and NREM sleep states (Fig. 3). 
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Indeed, unilateral MD of atropine into the KFN during nighttime studies 
significantly decreased V ̇i by 14% (P < 0.001) during NREM sleep and 
also, although not significantly, by 12% (P = 0.117) during 
wakefulness (Fig. 5). Bilateral MD of atropine significantly decreased V̇i 
by 12% during wakefulness (P < 0.01) and also by 12% during NREM 
sleep, although this decrease was not statistically significant (P = 
0.127) (Fig. 5). Unilateral and bilateral decreases in V ̇i were due to 
decreases of 13% (P < 0.001) and 12% (P < 0.001) in f, respectively, 
during wakefulness and NREM sleep (Fig. 5). In unilateral studies, Ti 
was increased by 18% (P < 0.05) during NREM sleep and marginally 
by 13% (P = 0.059) during wakefulness, whereas Te increased 19% (P 
< 0.001) during NREM sleep and 15% (P < 0.001) during wakefulness 
(Fig. 5). In bilateral studies, Ti increased by 15% (P < 0.05) during 
NREM sleep and 13% (P = 0.21) during wakefulness, with Te 
increased by 23% (P < 0.05) during NREM sleep and 19% (P < 0.001) 
during wakefulness (Fig. 5). The effects of atropine MD were in many 
cases observed during recovery from MD, which probably reflects a 
relatively slow washout of atropine from the tissue. There were no 
significant changes in Vt (data not shown). Ventilatory data during 
REM sleep are not available because there was an insufficient amount 
for analysis. 
 
Fig. 5. Unilateral and bilateral MD of atropine during nighttime studies in KFN animals 
(n = 6) decreased V̇i and f and increased Ti and Te during both awake and NREM sleep 
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states. There were no consistent and sustained changes in any variable during 
unilateral or bilateral MD of mCSF or atropine into the RPTN (n = 3), LPBN (n = 3), or 
MPBN (n = 4). Shaded boxes indicate periods of MD with either mCSF or atropine. *P 
< 0.05, significant differences from control. 
With two exceptions, there were no consistent and sustained 
changes in any ventilatory variable during MD at night into the RPTN, 
LPBN, and MPBN (Fig. 5). One exception was during unilateral MD of 
mCSF at night, when V ̇i decreased (P < 0.05) in MPBN goats by 18% 
(Fig. 5). The second exception was in RPTN goats when unilateral MD 
at night increased (P < 0.05) V ̇i by 18% during recovery from MD of 
mCSF (Fig. 5). These changes probably reflect effects of MD per se. 
There were no significant (P < 0.05) changes in the CV of any 
ventilatory variable during any study at all sites. 
Sleep.  
During the recovery period from bilateral MD of atropine into the KFN, 
the amount of NREM sleep (Fig. 6) was increased by 365% (P < 0.01). 
This increase in NREM sleep was presumably due to a stabilization of 
sleep mechanisms, as evidenced by a 990% (P < 0.001) increase in 
the average time per sleep epoch. During the recovery from unilateral 
MD of mCSF and atropine into the KFN, the time per sleep epoch was 
also significantly (P < 0.05) increased (Fig. 6). The percentage of time 
in NREM sleep was not significantly (P < 0.05) altered by MD of 
atropine into the RPTN, LPBN, or MPBN. 
 
Fig. 6. During the recovery period from bilateral MD of atropine into the KFN (n = 6), 
there was a significant (P < 0.05) increase in NREM sleep time and an increase the 
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duration of a NREM sleep epoch. During recovery from unilateral MD of either mCSF or 
atropine into the KFN, there was an increase in the duration of a NREM sleep epoch. 
During MD of mCSF or atropine into the RPTN (n = 3), LPBN (n = 3), or MPBN (n = 4), 
there were no significant effects of NREM sleep time or duration of NREM epoch. 
Shaded boxes indicate periods of MD with either mCSF or atropine. *P < 0.05, 
significant differences from control. 
Respiratory muscle activity.  
Compared with control levels, unilateral and bilateral MD of 
atropine had no significant (P < 0.05) effect on the quantified 
integrated diaphragm, abdominal, or genioglossus (GG) (Fig. 7) 
muscle activity during daytime or nighttime studies. However, 
beginning during the MD of mCSF and persisting through MD of 
atropine, the CV for GG activity during the day was increased by 68% 
(P < 0.001) in unilateral studies and by 47% (P < 0.001) in bilateral 
MD into the KFN (Fig. 8). There was no significant effect of MD on the 
CV for nighttime GG activity (Fig. 8). Furthermore, there was no 
significant effect on the variation of diaphragm or abdominal muscle 
activities. There were no data on GG activity for MD into the RPTN, 
because implantation of GG electrodes was added part way through 
the protocol and as such were not implanted in these initial animals. 
 
Fig. 7. There were no significant (P > 0.05) changes in the level of genioglossus (GG) 
muscle activity during MD of mCSF or atropine into the LPBN (n = 3), MPBN (n = 4), 
or KFN (n = 6) during daytime or nighttime studies. Shaded boxes indicate periods of 
MD with either mCSF or atropine. 
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Fig. 8. The coefficient of variation (CV; SD/mean × 100) for daytime GG muscle 
activity was increased during unilateral and bilateral MD of atropine into the KFN (n = 
6). There was no significant effect on the CV of GG activity during MD into the KFN at 
night, and there were no significant (P > 0.05) effects with MD into the LPBN (n = 3) 
or MPBN (n = 4) during daytime or nighttime studies. Shaded boxes indicate periods 
of MD with either mCSF or atropine. *P < 0.05, significant differences from control. 
Apneas and augmented breaths.  
MD into the RPTN during the day increased the mean number of 
apneas per total number of breaths compared with MD into the LPBN 
(P < 0.05), MPBN (P < 0.05), and KFN (P < 0.01) (data not shown). 
There were no other significant (P < 0.05) effects of MD on apneas or 
augmented breaths per total number of breaths during daytime or 
nighttime studies. 
Other physiological parameters.  
There were no significant consistent effects during the day or at 
night of unilateral or bilateral MD on PaCO2, PaO2, pHa, body 
temperature, V ̇o2, V ̇co2, heart rate, or arterial blood pressure (data not 
shown). All values were within normal limits for goats. 
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Discussion 
Summary.  
The major physiological changes observed in the present study 
are that unilateral and bilateral MD of atropine into the KFN at night 
decreased V̇i and f and increased Ti and Te by 12–23% during both 
wakefulness and NREM sleep. Our primary hypothesis regarding state-
dependent effects of attenuating muscarinic receptor activity in the 
PRG was not validated. 
Limitations.  
One constraint of this study was our inability to unequivocally 
define the anatomic region affected by MD of atropine. The grouping of 
the goats was based on the distal-most tract created by the implanted 
cannula. The MD probe was inserted 2 mm beyond the tip of the 
cannula; thus the membrane for reverse MD was within the designated 
area. However, atropine may have diffused beyond respective target 
nuclei. Exactly how far, and to what extent, atropine diffused was 
dependent on numerous factors including rate of diffusion, 
metabolism, and clearance of atropine. The anatomical morphology 
and tissue reaction to the cannulas and/or probes may have caused a 
difference in diffusion at different PRG sites and/or differences 
between goats. However, the finding that bilateral MD of atropine at 
each PRG subnucleus uniformly decreased ACh and choline in the 
effluent fluid compared with MD of mCSF provides indirect evidence 
that atropine reached the tissue at each site (Table 1). 
As shown in Fig. 2, the morphology of the LPBN and MPBN was 
quite different from that of the KFN. Compared with the KFN, the LPBN 
and MPBN are more widespread, larger in area, and contain more 
neurons. Accordingly, it was possible to only dialyze part of the LPBN 
and MPBN, whereas a relatively larger portion of the KFN was dialyzed 
when targeted; thus we cannot exclude the possibility of more 
prominent effects if atropine had been dialyzed into a larger portion of 
or in other parts of the LPBN and MPBN. Moreover, it is possible that 
the effective atropine concentration was not uniform at all PRG sites 
and during all periods of dialysis. It is conceivable that repeated 
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insertion of the dialysis probe destroyed neurons and/or altered 
diffusion characteristics, thereby causing nonuniform delivery of 
atropine. We were unable to determine for each group the potential 
damage caused by dialysis, because after completion of the six dialysis 
studies, in all but one goat we studied the effects of injecting the 
neurotoxin ibotenic acid. In the single goat in which ibotenic acid was 
not injected, the number of neurons distal to the cannula were within 
the normal variation of the control goats. Thus we did not obtain any 
evidence that MD per se affected the tissue within the region dialyzed. 
Another limitation of the present study is the small sample size 
in the LPBN, MPBN, and RTPN groups. As shown in Figs. 4 and 5, there 
were trends of changes induced by MD into these areas that might 
have been statistically significant if the number of goats was greater. 
Indeed, the power of some of the statistical analyses was less than 
0.2; thus, for groups with a low number of goats, we cannot state with 
confidence whether changes indeed did or did not occur. 
Because of these three limitations (uncertainty of diffusion 
distance and effective tissue atropine concentration, differences in 
morphology between PRG regions, and small sample size of 3 groups), 
it is inappropriate to conclude that there is a site-specific effect of 
atropine dialysis into the PRG. Our conclusion is that cholinergic 
modulation of KFN neurons contributes to the control of breathing 
during the night, but we cannot discount the possibility that cholinergic 
modulation of LPBN, MPBN, and RTPN neurons may also contribute to 
control of breathing. 
State-dependent changes in breathing.  
In most mammals, there is a decrease in breathing between 
wakefulness and NREM sleep. One postulated explanation for these 
changes is that the activity of serotonergic, adrenergic, and cholinergic 
neurons in the brain stem decreases between wakefulness and NREM 
sleep.6,27 If these are sources of excitatory neuromodulation of 
respiratory neurons, then the activity of respiratory neurons will be 
less during NREM sleep than during wakefulness. Indeed, it has been 
shown that the activity of PRG respiratory modulated neurons is less 
during NREM sleep than during wakefulness.16,30,33 Such reduced 
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excitation could then contribute to the reduced breathing during NREM 
sleep compared with wakefulness. 
If indeed cholinergic modulation is excitatory to PRG neurons 
and this excitatory effect is relatively greater during wakefulness than 
during NREM sleep, it seems appropriate to hypothesize that the effect 
of atropine attenuation of muscarinic activity in the PRG will be greater 
during wakefulness than during NREM sleep. However, we found that 
the effect of atropine MD into the KFN nearly equally reduced V ̇i during 
wakefulness and NREM sleep. In addition, during both states, the 
reduced V̇i resulted from reduced f secondary to increased Ti and Te. 
Accordingly, our data do not support the concept that lower KFN 
neuronal activity and lower V ̇i during NREM sleep are due to reduced 
excitatory cholinergic modulation of KFN neurons during NREM sleep 
relative to wakefulness. 
The data from several studies have led to the conclusion that 
increased ACh release into the mPRF promotes REM sleep and 
depresses breathing through an effect on PRG respiratory neurons.21 
We were unable to directly address this concept because of the 
minimal REM sleep in these goats. Nonetheless, our data do not 
provide support for the concept that there is a state-dependent effect 
of cholinergic modulation of breathing by PRG neurons. 
Day-night differences in effect of atropine.  
Except for a significant (P < 0.05) increase in Te during 
recovery from atropine MD into the LPBN, there were no other 
significant (P < 0.05) effects of atropine MD during the day; thus it is 
unlikely that cholinergic modulation of PRG neurons is a determinant of 
breathing during wakefulness during the day. The finding that atropine 
MD into the KFN depressed breathing during wakefulness at night but 
not during wakefulness during the day suggests that there is possibly 
a circadian component to cholinergic modulation of PRG neurons. The 
present study was not ideally designed to test for a circadian 
contribution to cholinergic modulation of breathing, because it would 
have required control of multiple variables, including feeding routine, 
standing vs. prone posture, behavior of chambermates, and visual 
cues associated with chronological time; thus our data do not establish 
a definitive circadian effect of cholinergic modulation. However, in 
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addition to sleep-dependent changes in neuromodulators, there also 
are documented circadian-dependent changes in neuromodulators. For 
example, serotonin levels in the pineal gland and the suprachiasmatic 
nucleus are lower in rats during the light cycle than during the dark 
cycle, and this difference appears to be controlled by circadian 
variation in adrenergic signaling.4,12,25,37,38 It is not known whether 
there are circadian variations in PRG cholinergic, adrenergic, and 
serotonin neuromodulation, but on the basis of our present findings, 
coupled with documented circadian variations in breathing,28,35 further 
studies are warranted on circadian variation of cholinergic modulation 
of PRG neurons. 
Cholinergic modulation of GG muscle activity.  
The tone of the pharyngeal GG muscle is reduced during NREM 
sleep, which reduces airway size and increases airway resistance, and 
in some humans this results in collapse of the airway (obstructive 
sleep apnea). The cause of these effects has not been established. 
Since there are projections from pontine cholinergic neurons32 to the 
hypoglossal nucleus, one potential contributing factor is altered 
cholinergic modulations of the motoneurons in the hypoglossal 
nucleus. Indeed, Kodama et al.19 found in decerebrate cats that 
microinjection of ACh into the rostral pons causes GG muscle atonia 
while simultaneously increasing both glycine and GABA release in the 
hypoglossal nucleus. Moreover, there are documented projections from 
the KFN to the hypoglossal nucleus,15,17,39 but the significance of these 
projections is unknown, leading Horner17 to conclude “it remains to be 
determined if modulation of central cholinergic activity importantly 
contributes to changes in GG activity across sleep-wake states.” 
Accordingly, we sought to determine whether attenuation of PRG 
muscarinic receptor activity with MD of atropine would affect GG 
muscle activity. We did not obtain any significant evidence that either 
the magnitude or variability of GG muscle activity was altered by MD 
of atropine into any PRG subnucleus during wakefulness and NREM 
sleep. The stable and constant muscle activity occurred even though 
multiple ventilatory variables were affected and NREM sleep was 
promoted during atropine MD into the KFN. 
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During the recovery from both unilateral and bilateral MD of 
mCSF into the KFN in daytime studies, variability in GG muscle activity 
began to increase, and it remained increased during and after MD of 
atropine. In addition, variability in GG muscle activity overall tended to 
be higher during the day than at night. Since pontine perturbations 
may affect a network with complex excitatory and inhibitory 
feedforward and feedback mechanisms that are postulated to 
contribute to the stabilization of breathing and respiratory muscle 
activity,13 it is not surprising that we found considerable variation in 
activity of the GG muscle. Disruption of this stabilizing role may 
contribute to sleep disordered breathing. However, the disruptions by 
MD per se and by MD of atropine during wakefulness and NREM sleep 
states in the present study did not cause profound destabilization 
characteristic of REM sleep. 
Effect of atropine MD on effluent ACh and choline and 
sleep.  
It seems that a logical consequence of attenuating muscarinic 
receptor activity in the PRG would be a compensatory increase in 
release of ACh. However, we found that MD of atropine resulted in a 
decrease in ACh and choline in the effluent dialysis fluid (Table 1). We 
are unable to explain this finding. However, the decrease in ACh may 
have contributed to two findings. First, the decreased ACh would 
seemingly have the same effect as attenuating muscarinic receptor 
activity with atropine. Indeed, the decrease in breathing during MD of 
atropine into the KFN could have been due to decreased ACh, rather 
than a direct effect of atropine on the muscarinic receptor. Second, a 
decrease in ACh also promotes NREM sleep; thus the increased 
amount of NREM sleep and increased in time per NREM sleep epoch 
during atropine MD into the KFN might be secondary to the decrease in 
ACh. 
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